Electromed, Inc.
AMEX:ELMDMedical - Devices
+$0.43 today
- Market cap
- $191.27M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
Volume 0.05M
Average 0.06M
ELMD Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Electromed, Inc.AMEX: ELMD
Depreciation & Amortization · Q3 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q3 FY2026 depreciation & amortization of $287K rose 1.4% year over year, behind the +12.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 70.8% from the prior quarter. Over 3 fiscal years it compounded at +23.1% a year.
Context
- Depreciation & amortization amounted to 1.8% of revenue in FY2025, up 0.3 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +1.4% toward the trailing-twelve-month pace of +12.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.17M USD
- Year-over-year change
- +39.4%
- 4-year CAGR
- +17.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 1.17M | +39.4% |
| FY2024 | 2024-06-30 | 841K | +37.2% |
| FY2023 | 2023-06-30 | 613K | -2.4% |
| FY2022 | 2022-06-30 | 628K | +3.0% |
| FY2021 | 2021-06-30 | 610K | — |
Depreciation & Amortization vs competitors
How ELMD compares with its peers on the latest reported figures
- ELMD's LTM Mar 2026 depreciation & amortization of $1.11M is the smallest of the 6 companies compared; the peer median is $29.62M.
- Its year-over-year change of +12.8% is the 2nd highest of 6, against a peer median of +3.5%.
- Depreciation & amortization amounts to 1.5% of revenue for ELMD, versus a peer median of 4.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $416.38M | +10.6% | +2.8% | 14.6% | |
| LTM Jun 2026 | $244.15M | +3.5% | +7.3% | 4.3% | |
| LTM Mar 2026 | $29.62M | +15.3% | +22.3% | 10.3% | |
| LTM Mar 2026 | $6.56M | -4.9% | +2.0% | 1.9% | |
| LTM Mar 2026 | $1.2M | -11.3% | -33.9% | 1.4% | |
| LTM Mar 2026 | $1.11M | +12.8% | +23.1% | 1.5% | |
| Peer median (excluding ELMD) | $29.62M | +3.5% | +2.8% | 4.3% | |
Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M |
| Depreciation & Amortization | 610K | 628K | 613K | 841K | 1.17M |
| Deferred Income Tax | (294K) | (489K) | (43K) | (571K) | (310K) |
| Stock-Based Compensation | 1.02M | 976K | 708K | 1.69M | 3.06M |
| Change in Working Capital | (625K) | (4.11M) | (3.13M) | 1.96M | (277K) |
| Accounts Receivables | (3.58M) | (3.91M) | (3.28M) | 565K | (1.64M) |
| Inventory | 971K | (1.07M) | (1.03M) | 459K | 175K |
| Accounts Payables | 214K | 2.17M | 420K | (1.21M) | 1.65M |
| Other Working Capital | 1.77M | (1.29M) | 763K | 2.14M | (458K) |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 212K |
| Operating Cash Flow | 3.08M | (686K) | 1.32M | 9.07M | 11.39M |
| Capital Expenditures | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (161K) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1.12M) | (1.45M) | (153K) | (275K) | (10M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (95K) | (77K) | (227K) | 311K | (1.88M) |
| Financing Cash Flow | (1.22M) | (1.53M) | (380K) | 36K | (11.88M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.41M | (3.74M) | (781K) | 8.71M | (793K) |
| Free Cash Flow | 2.63M | (2.21M) | (401K) | 8.67M | 11.09M |
Electromed, Inc.
AMEX:ELMD
Intrinsic Alpha fair value
Locked
Current Price
$23.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.